Genetically Engineered Blood Pharming：Generation of HLA-Universal Platelets Derived from CD34+Progenitor Cells

Publisher： Nova Science Publishers, Inc.

ISSN： 1556-8539

Source： Journal of Stem Cells, Vol., Iss., 2014-07, pp. : 27-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Table 1. Increase in the level of hematopoietic progenitor cells CD34+ in peripheral blood following seven transfusions to a 60-year-old patient of mononuclear fraction of peripheral blood from a 20-year-old donor [6]

By  

Journal of Stem Cells, Vol. , Iss. , 2016-04 ,pp. : 50-49

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Table 2. Reference values of hematopoietic progenitor cells CD34+ in peripheral blood of healthy individuals of various ages

By  

Journal of Stem Cells, Vol. , Iss. , 2016-04 ,pp. : 50-50

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Enucleation of CD34+ Derived Erythroid Cells

By  

Journal of Stem Cells, Vol. , Iss. , 2017-07 ,pp. : 32-31

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Characterization of CD34+ Cells

By  

Journal of Stem Cells, Vol. , Iss. , 2017-07 ,pp. : 33-33

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Isolation of CD34+ Stem Cells

By  

Journal of Stem Cells, Vol. , Iss. , 2017-07 ,pp. : 30-30

Nova Science Publishers, Inc.

Access to resources Recommend Favorite